While differentiated DC subsets were reduced, we found that Lineage− HLA-DR+ CD86+/– CD45RA+/– proliferating cells lacking typical DC markers were greatly expanded in the blood of COVID-19 patients. This evidence concerns the gene CD86 and COVID-19.